Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-21

FDA Approved: DOPTELET — Original Application (AkaRx, Inc.)

View source ↗

Summary

FDA approved DOPTELET (avatrombopag) from AkaRx, Inc. for reducing the need for platelet transfusions in adults with chronic liver disease undergoing an electiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOPTELET (avatrombopag)

Snippet

ORIG AP for DOPTELET (AVATROMBOPAG MALEATE)